- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02736877
Corneal Transplantation Guided by OCT RESCAN
Corneal Transplantation Guided by OCT RESCAN: Pre-op, Intra-op and Post-op Evaluation
The investigators will evaluate 30 patients with surgical indication for corneal transplantation. Participants will be divided according to the following diseases diseases: keratoconus, bullous keratopathy, corneal dystrophies. Participants will be informed about the risks and benefits of the study and sign an informed consent form. In the preoperative evaluation will be submitted to a complete ophthalmologic examination with complementary tests, such as optical coherence tomography.
One group of participants will undergo corneal surgery using the OCT Lumera microscope RESCAN - ZEISS and another group with a conventional microscope. Everyone will have their filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty about the ease of assessing corneal transplantation. After surgery, participants will be assessed on days 1, 7,15, 30, 60, 90 and 180 after surgery.
Surgeries and study procedures will be performed by the same team of surgeons and performed by IPEPO - Paulista Institute of Studies and Research in Ophthalmology / Vision Institute.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be allocated in one of the following groups:
- Control Group The control group will undergo corneal transplant with conventional microscope without coupled OCT. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation (ANNEX 1).
- Group OCT RESCAN In the group microscope coupled to OCT, patients will undergo retinal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation (ANNEX 1).
The investigators will evaluate intraoperative conditions, complications, operative time and postoperative results in both groups.
All patients will be monitored and evaluated with full ophthalmological examination in all postoperative visits (day 1, 7,15,30, 60, 90, 180) and will be subjected to the following tests:
- Measurement of visual acuity with best correction
- Previous Biomicroscopy
- Corneal Topography
- tonometry
- Optical coherence tomography (OCT)
- Microscopy speculate
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ricardo Nose, MD
- Phone Number: 5511 984471694
- Email: ricnose@gmail.com
Study Contact Backup
- Name: Luci Silva, PhD
- Phone Number: +551155726443
- Email: luci.silva@unifesp.br
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Visual acuity less than 20/60 in the affected eye
- 18 years at least
Diagnostic of the following diseases:
- keratoconus
- Keratopathy Bullosa
- Corneal dystrophy
Exclusion Criteria:
- Better visual acuity than or equal to 20/60
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lumera Microscope with OCT RESCAN
In the group microscope coupled to OCT, patients will undergo corneal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS.
The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation
|
corneal transplantation guided by Lumera Microscope with OCT RESCAN
|
Active Comparator: Conventional Microscope
The control group will undergo corneal transplant with conventional microscope without coupled OCT.
The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation
|
corneal transplantation guided by Conventional Microscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assess optimal maneuvers in corneal transplantation (separation layers)
Time Frame: Day 0
|
assessed by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare the time of surgery between groups
Time Frame: Day 0
|
by a questionnaire responded by surgeons (until 30 minutes, between 30-60 minutes, more than 60 minutes)
|
Day 0
|
To describe the surgical difficulty for corneal transplantation
Time Frame: Day 0
|
by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)
|
Day 0
|
Change of Day 1 Ocular inflammation at 1 month (Day 30)
Time Frame: from Day1 to Day30
|
ocular inflammation scored as mild, moderate or severe
|
from Day1 to Day30
|
Change from Baseline Intraocular Pressure at 6 months (Day180)
Time Frame: from Baseline to Day 180
|
intraocular pressure assessed by goldmann tonometer
|
from Baseline to Day 180
|
Change from Baseline Visual Acuity at 6 months (Day 180)
Time Frame: from Baseline to Day 180
|
visual acuity tested by ETDRS chart
|
from Baseline to Day 180
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Walton Nose, MD, PhD, Federal University of São Paulo UNIFESP
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RESCAN2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratoconus
-
The Cleveland ClinicUniversity of MarylandEnrolling by invitationKeratoconus | Keratoconus, Unstable | Keratoconus, StableUnited States
-
Eye Hospital Pristina KosovoActive, not recruitingKeratoconus | Keratoconus of Right Eye | Keratoconus, Unstable, Right EyeKosovo
-
Tianjin Eye HospitalRecruitingScansys, Pentacam, Keratoconus, Subclinical KeratoconusChina
-
Tianjin Eye HospitalActive, not recruitingScansys, Pentacam, Corvis ST, Keratoconus, Subclinical KeratoconusChina
-
Heba Allah Nashaat MohamedAssiut UniversityRecruitingKeratoconus, CollagenEgypt
-
Kent Wellish MDNot yet recruitingKeratoconus, Unstable
-
Kasr El Aini HospitalUnknownProgressive KeratoconusEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedProgressive Keratoconus
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Tianjin Eye HospitalCompletedKeratoconus, StableChina
Clinical Trials on Lumera Microscope with OCT RESCAN
-
Federal University of São PauloInstituto Paulista de Estudos e Pesquisa em OftalmologiaUnknownEpiretinal Membrane | Proliferative Vitreoretinopathy | Macular Hole | Traction Syndrome Vitreomacular
-
Northwestern UniversityTerminatedGlaucoma | Glaucoma Following SurgeryUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownEffectiveness of Microscope During Apical Surgery in Endodontic Treated Teeth.Netherlands
-
Prof. Dr. Thomas LuftRecruitingEndothelial Dysfunction | Hematological NeoplasmGermany
-
Anna Rita Daniele, MDAlcon ResearchCompletedComparison of 3D Visualization and Microscope for VR SurgeryItaly
-
St. Francis Hospital, New YorkCardioVascular Research Foundation, KoreaUnknownCoronary Artery DiseaseUnited States
-
Duke UniversityNational Institute on Aging (NIA)Enrolling by invitationOptical Coherence Tomography of RetinaUnited States
-
Topcon CorporationCompletedFluorescein Angiography ImagingUnited States
-
Heidelberg Engineering GmbHDuke UniversityActive, not recruitingRetinal Disease | Healthy EyesUnited States
-
Erasmus Medical CenterRecruitingCoronary Artery Disease | Stable Angina | Percutaneous Coronary Intervention | Unstable Angina | Multi Vessel Coronary Artery Disease | Non-ST Elevation Myocardial Infarction | Optical Coherence TomographyNetherlands